Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products

被引:12
|
作者
Sun, Hong [1 ]
Yuan, Yang [1 ]
Sun, Zilin [1 ]
机构
[1] Southeast Univ, Sch Med, Inst Diabet, Dept Endocrinol,Zhongda Hosp, Nanjing 210009, Jiangsu, Peoples R China
关键词
ENDOPLASMIC-RETICULUM STRESS; ER STRESS; DIABETIC-NEPHROPATHY; SERUM-LEVELS; CHOLESTEROL; PATHWAY; CELLS; ACCUMULATION; METABOLISM; RECEPTOR;
D O I
10.1155/2016/5475120
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Diabetic nephropathy (DN) caused by advanced glycation end products (AGEs) may be associated with lipid accumulation in the kidneys. This study was designed to investigate whether N epsilon-(carboxymethyl) lysine (CML, a member of the AGEs family) increases lipid accumulation in a human renal tubular epithelial cell line (HK-2) via increasing cholesterol synthesis and uptake and reducing cholesterol efflux through endoplasmic reticulum stress (ERS). Our results showed that CML disrupts cholesterol metabolism in HK-2 cells by activating sterol regulatory element-binding protein 2 (SREBP-2) and liver X receptor (LXR), followed by an increase in 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoAR) mediated cholesterol synthesis and low density lipoprotein receptor (LDLr) mediated cholesterol uptake and a reduction in ATP-binding cassette transporter A1 (ABCA1) mediated cholesterol efflux, ultimately causing lipid accumulation in HK-2 cells. All of these responses could be suppressed by an ERS inhibitor, which suggests that CML causes lipid accumulation in renal tubule cells through ERS and that the inhibition of ERS is a potential novel approach to treating CML-induced renal tubular foam cell formation.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Advanced Glycation End Products and Psoriasis
    Maurelli, Martina
    Gisondi, Paolo
    Girolomoni, Giampiero
    VACCINES, 2023, 11 (03)
  • [42] Advanced glycation end products and allergy
    Masako Toda
    Michael Hellwig
    Hiroyuki Hattori
    Thomas Henle
    Stefan Vieths
    Allergo Journal International, 2023, 32 (7) : 296 - 301
  • [43] Advanced glycation end products and nutrition
    Krajcovicová-Kudlácková, M
    Sebeková, K
    Schinzel, R
    Klvanová, J
    PHYSIOLOGICAL RESEARCH, 2002, 51 (03) : 313 - 316
  • [44] Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products
    Babtan, Anida M.
    Ilea, Aranka
    Bosca, Bianca A.
    Crisan, Maria
    Petrescu, Nausica B.
    Collino, Massimo
    Sainz, Rosa M.
    Gerlach, Jared Q.
    Campian, Radu S.
    BIOMARKERS IN MEDICINE, 2019, 13 (06) : 479 - 495
  • [45] ADVANCED GLYCATION END PRODUCTS, SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND RISK OF LIVER CANCER.
    Moy, K. A.
    Jiao, L.
    Freedman, N. D.
    Weinstein, S. J.
    Sinha, R.
    Virtamo, J.
    Albanes, D.
    Stolzenberg-Solomon, R. Z.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S103 - S103
  • [46] Formation mechanisms of melanoidins and fluorescent pyridinium compounds as advanced glycation end products
    Hayase, Fumitaka
    Usui, Teruyuki
    Ono, Yoriyuki
    Shirahashi, Yoshinobu
    Machida, Tomomi
    Ito, Takashi
    Nishitani, Nozomu
    Shimohira, Kazuhito
    Watanabe, Hirohito
    MAILLARD REACTION: RECENT ADVANCES IN FOOD AND BIOMEDICAL SCIENCES, 2008, 1126 : 53 - 58
  • [48] Receptor for advanced glycation end products (RAGE) and acute lung injury (ALI)
    Izushi, Yasuhisa
    Wake, Hidenori
    Liu, Keyue
    Takahasi, Hideo
    Mori, Shuji
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 206P - 206P
  • [49] Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease
    Hartog, JWL
    De Vries, APJ
    Lutgers, HL
    Meerwaldt, R
    Huisman, RM
    Van Son, WJ
    De Jong, PE
    Smit, AJ
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 299 - 307
  • [50] Soluble receptor for advanced glycation end products in patients with decreased renal function
    Kalousová, M
    Hodková, M
    Kazderová, M
    Fialová, J
    Tesar, V
    Dusilová-Sulková, S
    Zima, T
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (03) : 406 - 411